Berry Consultants, LLC

Berry Consultants, LLC is a scientific consulting company based in Austin, Texas, that specializes in innovative adaptive clinical trial design, Bayesian analysis, trial implementation, and software solutions for the pharmaceutical and medical device industry. According to its official website, the firm provides innovative statisticians and software that give clients the freedom to design and implement adaptive clinical trials, supporting them from analysis to approval and beyond. Its stated philosophy is "Innovative Trials, Better Outcomes," reflecting a belief that adaptive trials can yield better insights, greater efficiency, better treatment for trial participants, and better information for regulators and the medical community. The company's core service lines include adaptive clinical trial design, trial implementation, clinical trial software, and platform trials. In adaptive design, Berry helps sponsors pre-specify flexible components of major trial aspects such as treatment arms, allocation to treatment arms, patient population, and sample size. Its implementation services cover interim and final analyses for primary and key secondary efficacy endpoints, expert guidance on best practices for adaptive design implementation, and interaction with Data Safety Monitoring Boards (DSMB) for adaptive and platform trials. On the software side, Berry offers tools that help biostatisticians rapidly design, compare, and simulate both fixed and adaptive trial designs through powerful, versatile, and fast simulation tools. Berry's flagship software is FACTS (Fixed and Adaptive Clinical Trial Simulator), described on its website as the industry's most powerful tool for designing, simulating, and analyzing adaptive clinical trials. FACTS spans capabilities from phase I dose escalation trials to adaptive platform trial designs, helping teams design custom trials to fit their unique clinical goals. The firm also promotes platform trials — innovative clinical trials that evaluate multiple treatments simultaneously and are intended to continue beyond the evaluation of any one treatment, while maximizing statistical and clinical efficiency. Berry positions itself as a pioneer of Bayesian and adaptive approaches, noting that long before "adaptive" and "Bayesian" became industry buzzwords, it was pioneering these approaches alongside its clients to create trials that learn, evolve, and succeed. Unlike routine statistical consulting, the company says it focuses on pushing the boundaries of trial design, producing innovative, bespoke solutions that tackle the most complex challenges in clinical research, from exploratory early-phase studies to pivotal late-phase trials. The firm's therapeutic experience is broad. Featured areas listed on its website include Alzheimer's disease, COVID-19, oncology, rare diseases, sepsis, and stroke, with an extensive additional list covering conditions such as amyotrophic lateral sclerosis, breast cancer, chronic kidney disease, diabetes, Duchenne muscular dystrophy, glioblastoma, heart failure, HIV, lupus, multiple myeloma, multiple sclerosis, non-small cell lung cancer, obesity, Parkinson's disease, and many others. Berry also maintains a podcast, "In the Interim," and publishes news and events for its community. Wikidata identifies Berry Consultants, LLC as a company in Austin, United States.

Berry Consultants, LLC is a scientific consulting company based in Austin, Texas, United States, as identified by Wikidata. The firm specializes in innovative adaptive clinical trial design, Bayesian analysis, implementation, and software solutions for the pharmaceutical and medical device industry. Its official website states that it has extensive experience in the design, implementation, and software solutions of adaptive clinical trials across many medical disciplines. The company describes itself as having pioneered Bayesian and adaptive approaches long before "adaptive" and "Bayesian" became industry buzzwords, working alongside clients to create trials that learn, evolve, and succeed. This positioning frames Berry not as a routine statistical consulting practice but as a firm focused on pushing the boundaries of trial design and delivering bespoke solutions for complex clinical research challenges, from exploratory early-phase studies to pivotal late-phase trials. Over time, Berry has built a service portfolio spanning adaptive clinical trial design, trial implementation, clinical trial software, and platform trials. Its implementation services include interim and final analyses for primary and key secondary efficacy endpoints, expert guidance on best practices for adaptive design implementation, and interaction with Data Safety Monitoring Boards (DSMB) for adaptive and platform trials. The firm's software offerings help biostatisticians rapidly design, compare, and simulate both fixed and adaptive trial designs. A central element of Berry's history and identity is FACTS (Fixed and Adaptive Clinical Trial Simulator), which the company describes as the industry's most powerful tool for designing, simulating, and analyzing adaptive clinical trials. FACTS supports capabilities from phase I dose escalation trials to adaptive platform trial designs. Berry has also been active in promoting platform trials — trials that evaluate multiple treatments simultaneously and are intended to continue beyond the evaluation of any one treatment. Berry's therapeutic experience is broad and spans many medical disciplines. Featured areas on its website include Alzheimer's disease, COVID-19, oncology, rare diseases, sepsis, and stroke, alongside an extensive list of additional conditions. The company also engages its community through a podcast, "In the Interim," and publishes news and events. Specific founding dates, founders, ownership, and financial details are not provided in the available evidence.

A scientific consulting firm positioning itself as a pioneer of Bayesian and adaptive clinical trial design, offering bespoke, innovative solutions and simulation software for the pharmaceutical and medical device industry.

• FACTS (Fixed and Adaptive Clinical Trial Simulator)

  Described by Berry as the industry's most powerful tool for designing, simulating, and analyzing adaptive clinical trials, with capabilities spanning from phase I dose escalation trials to adaptive platform trial designs.

• Adaptive Clinical Trial Design

  Allows the pre-specification of flexible components to major aspects of a trial, such as treatment arms, allocation to treatment arms, patient population, and sample size.

• Trial Implementation

  Includes interim and final analyses for primary and key secondary efficacy endpoints, expert guidance on best practices for adaptive design implementation, and interaction with Data Safety Monitoring Boards (DSMB) for adaptive and platform trials.

• Platform Trials

  Innovative clinical trials that evaluate multiple treatments simultaneously and are intended to continue beyond the evaluation of any one treatment, while maximizing statistical and clinical efficiency.

1. 1Berry Consultants | Bayesian Clinical Trial Design, Adaptive Trials & FACTS Softwareberryconsultants.com
2. 2About | Berryberryconsultants.com
3. 3Bayesian Clinical Trial Design Services | Expert Consulting | Berry Consultantsberryconsultants.com
4. 4Therapeutic Areas by Berryberryconsultants.com
5. 5Berry Consultants, LLC (United States) - Wikidatawikidata.org